Beauty Comparison

IPL Treatment: What It Does for Sun Spots & Redness

Reviewed June 2026 9 min read 5 sources

The short answer

Intense Pulsed Light (IPL) delivers polychromatic light across approximately 400–1,400 nm wavelengths to target melanin (sun spots, freckles, lentigines) and hemoglobin (facial redness, telangiectasia, rosacea) via selective photothermolysis.

What Is IPL?

Intense Pulsed Light (IPL) — sometimes called a photofacial or fotofacial — is a light-based skin treatment that uses filtered broadband light to target and destroy specific chromophores in the skin: melanin (the pigment in sun spots, freckles, and uneven tone) and oxyhemoglobin (the molecule in dilated blood vessels that causes facial redness and visible telangiectasia).

It is important to understand what IPL is not: IPL is not a laser. Lasers emit a single, coherent wavelength of light. IPL devices produce polychromatic (multi-wavelength) light across a broad spectrum — approximately 400–1,400 nm — and use cut-off filters to narrow the range for specific targets. This distinction matters clinically: IPL's broader spectrum allows it to target multiple chromophores in a single pass, but it also makes it less precise than a targeted laser for any single problem.

IPL is FDA-cleared for treating lentigines (age spots / sun spots), telangiectasias, erythema from rosacea, and general photorejuvenation. It is also used for hair removal and, more recently, for dry eye disease — demonstrating how versatile the technology is.


How IPL Works: Selective Photothermolysis

IPL operates on the principle of selective photothermolysis: the selective absorption of light energy by a specific chromophore, converting it to heat and thermally destroying the target while leaving surrounding tissue minimally affected.

Targeting Melanin (Sun Spots, Freckles, Lentigines)

Solar lentigines and ephelides (freckles) are areas of abnormally high epidermal melanin concentration. When IPL energy — typically delivered in the 515–600 nm range with appropriate filters — is absorbed by melanin, the chromophore heats rapidly. The melanin-containing cells (melanocytes and surrounding keratinocytes) are thermally disrupted. Within days, the darkened area temporarily darkens further before flaking off as the dead cells shed naturally. This "pepper and salt" darkening immediately after treatment is normal and expected.

Targeting Oxyhemoglobin (Redness, Telangiectasia, Rosacea)

For vascular targets — the dilated capillaries and flushed skin of rosacea, spider veins (telangiectasia), and diffuse erythema — IPL uses longer wavelengths (typically 530–950 nm or specific vascular filters around 540–700 nm). Oxyhemoglobin absorbs this energy, generating heat that coagulates the vessel wall without rupturing it. The collapsed vessel is then gradually reabsorbed by the body over 1–4 weeks, reducing visible redness.

Near-infrared wavelengths within the IPL spectrum (800–1,200 nm) penetrate deeper into the dermis, absorbed by water in tissue. This mild coagulative heating activates fibroblasts and stimulates collagen production, contributing to the photorejuvenation effects — improved skin texture and overall tone — that users notice beyond spot and redness clearance.


What IPL Treats: Evidence Summary

Sun Spots (Solar Lentigines) and Freckles (Ephelides)

Solar lentigines and ephelides are among the most responsive targets for IPL. The high melanin concentration in these lesions relative to surrounding skin creates strong selective absorption contrast, allowing effective treatment with minimal effect on surrounding skin.

A landmark study published in Photomedicine and Laser Surgery showed that IPL produces measurable reductions in sun-damaged skin; a subsequent analysis found that effects on sun-damaged human skin included both morphologic and ultrastructural improvements in the dermis as well as clearance of pigmented lesions. Results are typically visible within 1–2 weeks as treated spots darken and shed.

Facial Redness and Rosacea (Erythematotelangiectatic)

Rosacea — particularly the erythematotelangiectatic subtype with diffuse redness and visible vessels — has an established evidence base for IPL treatment. A prospective clinical study published in PMC (2025) treating 82 patients found:

  • 69.5% achieved greater than 75% lesion clearance
  • 30.5% achieved 51–75% clearance
  • Zero patients experienced less than 50% clearance
  • 64.6% of physician assessments rated improvement as "optimal"
  • 95.1% of patients reported "very high" satisfaction
  • Average 2.4 sessions needed; visible improvement seen within 3 days of the final session

A separate study analyzing 39 patients with rosacea and telangiectasia treated with a vascular chromophore-specific IPL system found all patients achieved at least moderate improvement, with 21/39 (54%) reaching excellent improvement. No post-inflammatory hyper- or hypopigmentation was observed.

The Indian Journal of Dermatology, Venereology and Leprology systematic review on IPL for rosacea further supports its efficacy and safety across multiple clinical studies.

Telangiectasia (Spider Veins on the Face)

Facial telangiectasias — dilated capillaries visible on the nose, cheeks, and chin — respond predictably to IPL. The vascular destruction mechanism (oxyhemoglobin absorption → vessel coagulation → reabsorption) is well-established. IPL is considered first-line for diffuse facial telangiectasia; for isolated individual vessels, pulsed dye laser (PDL) may be slightly more precise.

Photorejuvenation (General Photoaging)

Beyond discrete spots and vessels, IPL is commonly used for diffuse photorejuvenation — improving overall skin tone, texture, and luminosity in sun-damaged skin. The combination of epidermal melanin clearance and dermal collagen stimulation produces a more even complexion. Results for generalized photoaging are gradual and moderate; IPL is not a substitute for ablative or fractional laser resurfacing for significant wrinkles or deep scarring.


IPL vs. Laser: Key Differences

Feature IPL Laser (e.g., CO2, Nd:YAG)
Light type Broadband, non-coherent, multi-wavelength Coherent, single wavelength
Precision Moderate — broad spectrum targets multiple chromophores High — single target
Downtime Minimal (1–2 days redness) Variable — hours to weeks
Skin ablation No — non-ablative Ablative or non-ablative depending on type
Best for Sun spots, redness, rosacea, telangiectasia Deep wrinkles, scars, precise vascular lesions
Sessions 3–6 for optimal results 1–6 depending on type
Darker skin risk Moderate — not suitable for Fitzpatrick V–VI Varies by laser type

For acne scars and deep wrinkles, fractional laser resurfacing is the more appropriate choice — see laser skin resurfacing guide and laser acne scar treatment for a full comparison.


Who Is a Good Candidate for IPL?

Ideal candidates:

  • Fitzpatrick skin types I–IV with sun damage, freckles, solar lentigines, or facial redness
  • Patients with erythematotelangiectatic rosacea (diffuse redness and telangiectasia)
  • Those seeking mild photorejuvenation with minimal downtime
  • Patients who cannot commit to the longer recovery of ablative laser resurfacing

Who should avoid IPL:

  • Fitzpatrick types V–VI — very dark skin tones have high melanin content throughout the epidermis; IPL cannot adequately distinguish lesion melanin from surrounding skin melanin, risking paradoxical pigmentation changes and burns
  • Active suntan or recent UV exposure — elevated baseline melanin competes with lesion melanin, increasing burn risk
  • Pregnant or breastfeeding patients — elective aesthetic procedures are deferred during pregnancy
  • Patients with active herpes simplex — the thermal stimulus can trigger reactivation; all patients with a cold sore history should receive prophylactic antiviral medication
  • Patients on photosensitizing medications — certain antibiotics (doxycycline, tetracycline), retinoids, and NSAIDs can increase light sensitivity and adverse event risk
  • History of photosensitive conditions — lupus, porphyria, and similar conditions are contraindications
  • Recent waxing or laser hair removal — avoid within 2–4 weeks of IPL

What to Expect: Sessions and Protocol

IPL is performed as an outpatient treatment, typically in a dermatologist's or physician's office or medical aesthetics clinic. The procedure itself takes 20–30 minutes for a full face.

Before Treatment

  • Arrive with a clean face — no makeup, retinoids, or active ingredients for 24–48 hours before
  • Avoid tanning and direct sun for at least 2–4 weeks prior
  • Disclose all medications (especially photosensitizers and anticoagulants) and your herpes simplex history
  • Provider will clean the skin and apply cool ultrasound gel to the treatment area; protective eyewear (goggles) is worn throughout

During Treatment

Each light pulse covers a small rectangular area (typically around 3 cm²). Patients describe the sensation as a rubber band snap or a brief warm snap. Pain is generally rated as low to moderate — in the rosacea study above, 39% of patients reported low pain and 46.3% reported medium pain, with no patient requiring injectable anesthesia.

Sessions are spaced 2–4 weeks apart. Most protocols involve 3–6 sessions; the rosacea study above achieved excellent results in an average of 2.4 sessions for that specific indication.

After Treatment

  • Immediate redness and mild swelling are normal and typically resolve within 4–24 hours
  • Treated sun spots will appear darker ("the coffee ground effect") for 5–7 days before flaking off — do not pick or exfoliate these
  • Treated vessels may appear temporarily darker or bruised before fading over 1–2 weeks
  • Avoid direct sun, heat (saunas, hot showers) for 48 hours post-treatment
  • Apply gentle moisturizer and SPF 30+ from the day after treatment; mineral sunscreen is preferred in the first few days
  • Resume normal skincare after 48–72 hours, except retinoids (wait at least 5–7 days)

Side Effects and Risks

Common and expected:

  • Redness and mild swelling for 24–48 hours
  • Temporary darkening of treated pigmented lesions before shedding (normal)
  • Transient bruising over treated vessels

Less common:

  • Hyperpigmentation — particularly in higher Fitzpatrick types (III–IV) or patients who resume UV exposure too quickly; managed with post-treatment hydroquinone if persistent
  • Hypopigmentation — light spots where pigment is over-destroyed; more common in darker skin types with poorly calibrated fluence
  • Blister formation — rare; usually indicates excessive fluence or undertanning assessment
  • Paradoxical hypertrichosis — rare but documented paradoxical hair growth in the treated area, especially in darker skin types; mechanism not fully understood

Rare but serious:

  • Burn and scarring — from inadequate cooling, excessive fluence, or treatment of contraindicated skin type
  • Herpes simplex reactivation — managed with prophylactic antivirals started 1–2 days before treatment

How Many Sessions and What Are the Results?

Results are cumulative and session-dependent. For photorejuvenation and mild sun spots, improvements begin after the first session but are modest; the full benefit emerges after a complete course of 3–6 treatments.

  • Session 1–2: Noticeable fading of discrete sun spots; mild improvement in redness
  • Session 3–4: Continued lesion clearance; improved overall even tone; redness reduction becomes more pronounced
  • Session 5–6: Optimal clearance in most patients; some patients reach full clearance in fewer sessions

Results typically last 1–2 years before sun-related recurrence begins. Maintenance sessions every 12–18 months can sustain results. The single most important maintenance factor is daily broad-spectrum SPF 30+. UV exposure directly re-stimulates melanocytes and damages vessels — without sun protection, treated lesions recur faster.


IPL for Rosacea: Special Considerations

IPL is among the most effective non-pharmacological treatments for the erythematotelangiectatic subtype of rosacea — the form characterized primarily by diffuse redness, flushing, and visible vessels (as opposed to papulopustular rosacea with acne-like breakouts).

IPL does not cure rosacea; it reduces visible manifestations and decreases trigger responsiveness for months at a time. Combination approaches — IPL alongside topical brimonidine, azelaic acid, or metronidazole — are commonly used. The rosacea guide covers the full management landscape. Papulopustular rosacea may need topical or oral antibiotics as the primary intervention; IPL addresses the vascular component as an adjunct.


IPL vs. Laser for Sun Spots: Which Is Better?

For isolated, discrete solar lentigines (age spots), both IPL and targeted Q-switched or picosecond lasers are effective. Q-switched Nd:YAG and picosecond lasers (e.g., 532 nm or 755 nm) can target individual lesions with single-session resolution. IPL treats a broader area in fewer total passes, making it more efficient for widespread diffuse pigmentation.

For a face with both diffuse redness and scattered sun spots simultaneously, IPL's dual chromophore targeting capability makes it more practical than using separate laser wavelengths for each concern.

Products that fit: sensitive skin

Picked by code from each product's full ingredient list.

Affiliate

Amazon UK prices as of 6 November 2026, 04:30 GMT; Amazon sets the final price at checkout.

See the full guide: Best Moisturizers for Sensitive Skin →

Frequently asked questions

What does the current evidence say about IPL for sun spots and redness in 2026?

The evidence base for IPL in treating solar lentigines (sun spots), facial telangiectasia, and rosacea is well-established and has not changed significantly in 2026. A prospective study published in 2025 in PMC found 69.5% of patients achieved greater than 75% lesion clearance for rosacea/telangiectasia after an average of 2.4 IPL sessions, with 95.1% patient satisfaction. Systematic reviews of IPL for rosacea confirm consistent efficacy across multiple clinical studies. IPL remains a first-line recommendation for diffuse facial redness and sun damage with a strong safety record when correctly performed on appropriate skin types.

How many IPL sessions do I need for sun spots?

Most patients require 3–6 sessions spaced 2–4 weeks apart for optimal sun spot clearance. However, individual response varies: patients with well-defined, superficial solar lentigines on lighter skin tones may see significant clearing after 2–3 sessions. Darker, deeper, or more diffuse pigmentation typically requires the full course. Improvement begins visibly after the first session — treated spots temporarily darken before shedding within 5–7 days — but the cumulative effect across the full course is substantially greater than any single session.

Is IPL safe for darker skin tones?

IPL carries elevated risk for Fitzpatrick skin types V and VI, and most providers will not perform IPL on very dark skin. The broad-spectrum light cannot adequately distinguish the high baseline melanin in darker skin from the target lesion melanin, increasing the risk of burns, hyperpigmentation, and hypopigmentation. Fitzpatrick types III–IV can often be treated with careful settings, experienced providers, and appropriate filters, but require more conservative fluences and spacing. For darker skin tones seeking to address sun spots, targeted Q-switched Nd:YAG laser (1,064 nm) or picosecond laser may be safer alternatives — discuss with a board-certified dermatologist experienced in treating skin of color.

Does IPL hurt?

IPL is generally well-tolerated. The sensation is typically described as a series of rubber-band snaps or brief warm pulses — uncomfortable but not severely painful. Clinical studies rate pain as low to moderate, with most patients not requiring injectable anesthesia. Providers apply cooling gel and devices include contact cooling to minimize discomfort. Sensitive areas (nose, hairline, bony prominences) may feel more intense. If significant pain occurs, communicate with your provider immediately as this may indicate settings are too aggressive for your skin tone.

How long do IPL results last?

IPL results for sun spots and redness typically last 1–2 years before notable recurrence. The key determinant of longevity is sun protection behavior: patients who use broad-spectrum SPF 30+ daily and avoid unprotected UV exposure maintain results significantly longer than those who do not. Maintenance sessions every 12–18 months are commonly recommended. Rosacea, as a chronic condition, will continue to evolve independently of IPL treatment — IPL reduces current manifestations but does not alter the underlying predisposition.

What is the difference between IPL and a photofacial?

They are the same thing. 'Photofacial' (also spelled 'fotofacial') is a marketing term for IPL photorejuvenation performed on the face. Some providers use it specifically to describe an IPL protocol targeting both pigmentation and vascular concerns simultaneously — exactly what IPL's broad spectrum makes it suited for. When comparing clinic offerings, always ask which specific device is being used; IPL device quality and filter options vary substantially between manufacturers.

Health information, not medical advice.

Beauty Comparison is an independent editorial publication. This page is researched and sourced to the authorities listed below, but it is general information — not a diagnosis or a substitute for personalised advice from a qualified doctor, dermatologist or pharmacist. If your symptoms are severe, spreading, painful, or not improving, see a healthcare professional.

Sources

  1. 01Intense Pulsed Light (IPL) Therapy — StatPearls — NCBI Bookshelf / StatPearls (National Library of Medicine). IPL uses polychromatic light across 400–1,400 nm via selective photothermolysis targeting melanin and hemoglobin; FDA-approved indications include telangiectasias, melasma, lentigines, rosacea, photorejuvenation; 3–6 treatments every 2–4 weeks standard; contraindications include pregnancy, active sunburn, HSV history; Fitzpatrick V–VI elevated risk; paradoxical hypertrichosis documented.
  2. 02Effective Treatment of Rosacea and Telangiectasias Using IPL — PubMed Central, 2025-01-01. Prospective study of 82 patients: 69.5% achieved >75% lesion clearance, 30.5% achieved 51–75% clearance, zero patients <50% clearance; 64.6% physician assessments rated 'optimal'; 95.1% patients reported 'very high' satisfaction; average 2.4 sessions; visible improvement within 3 days of final session; fluence 5–30 J/cm², pulse 10–15 ms, 4-week intervals.
  3. 03Effective Treatment of Rosacea and Other Vascular Lesions Using IPL Emitting Vascular Chromophore-Specific Wavelengths — PubMed Central / Clinical, Cosmetic and Investigational Dermatology, 2024-03-01. 39 patients with rosacea and telangiectasia treated with vascular-specific IPL filters (500–677 nm and 854–1,200 nm); all patients improved, 21/39 excellent, 13/39 good, 3/39 moderate; no post-inflammatory hyper/hypopigmentation; three monthly sessions; almost all patients reported minimal pain.
  4. 04Effects of Intense Pulsed Light on Sun-Damaged Human Skin, Routine, and Ultrastructural Analysis — PubMed / Dermatologic Surgery, 2002-02-01. IPL on sun-damaged skin induced morphologic changes including improvements in dyspigmentation and vascular lesions; ultrastructural analysis showed dermal changes consistent with collagen remodeling contributing to photorejuvenation effects.
  5. 05Ablative Fractional Carbon Dioxide Laser Combined with IPL for Photoaging in Chinese Population — PubMed Central / Journal of Cosmetic Dermatology, 2018-02-01. IPL device affects redness and dyspigmentation via broad spectrum 515–1200 nm emissions; combination with ablative fractional CO2 demonstrates complementary mechanisms; IPL targets melanin and hemoglobin via selective photothermolysis.